Skip to content
sellNotable cluster of 2

Niklason Laura E sold $6.6M of HUMA

President, CEO and Director at Humacyte, Inc.. 1,500,000 shares at an average of $4.40, traded Nov 18, 2024, filed Nov 20, 2024.

Warning score
68
Value
$6.6M
1,500,000 shares
Holdings after
1,730,884
-46% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001818382-24-000208, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 18, 2024SOpen-market sale
Common Stockindirect: By Ayabudge LLC
-811,172$4.44$3.6M2,419,712Nov 20, 2024
Nov 19, 2024SOpen-market sale
Common Stockindirect: By Ayabudge LLC
-427,459$4.34$1.9M1,992,253Nov 20, 2024
Nov 20, 2024SOpen-market sale
Common Stockindirect: By Ayabudge LLC
-261,369$4.40$1.2M1,730,884Nov 20, 2024

Related signals

Other insiders at Humacyte, Inc. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
21WeakbuyHUMA
Humacyte, Inc.
Constantino Michael T.
director
$20k4,600
18Weakbuy 2HUMA
Humacyte, Inc.
Dougan Brady W
director
$7,9791,797
28Weakbuy 2HUMA
Humacyte, Inc.
Niklason Laura E
President, CEO and Director
$7,9791,797
58Moderatesell 2HUMA
Humacyte, Inc.
Dougan Brady W
director
$6.6M1,500,000

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Niklason Laura E sold $6.6M of HUMA | InsiderTell